Edwards Lifesciences Corporation (EW)

EW price $90.82 +0.26 +0.29%

Ticker
EW
Price
$90.82
Change
+0.26 +0.29%
Market cap ?
$52.35B
P/E ?
52.05
Forward P/E ?
30.29
Dividend yield ?
0.00%
Beta ?
0.86
Sector
Healthcare
Industry
Medical - Devices
Stocklytics score
49
Value
29
Quality
79
Growth
38

Stocklytics score rationale: value 29, quality 79, growth 38.

Financials

2016201720182019202020212022202320242025
2963700000343530000037228000004348000000438630000052325000005382400000501000000054395000006067600000

Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio…

Fair value

EW fair value $101.16. Price $90.82. Price is 10% below fair value.

Above fair value, and more expensive than usual. A larger premium than on 86% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 1.43B. Growth 11.57% in year 1, held for five years, then fading in a straight line to terminal growth by year 10. Year-1 growth is analyst revenue growth, or 5-year historical revenue growth when that forecast is missing, kept between 0% and 20%. Terminal growth 3.00%. Discount rate 9.05% (beta 0.9). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. Years 1 to 5 grow at the year-1 rate, and years 6 to 10 fade in a straight line to terminal growth of 3%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 576.40M. Net debt -2.23B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare EW

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—0.74—1.68B
2026-07-230.780.741.74B1.70B
2026-04-230.780.731.65B1.60B
2026-02-100.580.621.57B1.55B
2025-10-300.670.601.55B1.50B
2025-07-240.670.621.53B1.49B
2025-04-230.640.601.41B1.40B
2025-02-110.590.551.39B1.36B
2024-10-240.670.671.35B1.54B
2024-07-240.700.691.39B1.65B
2024-04-250.660.641.60B1.57B
2024-02-060.640.641.53B1.49B
2023-10-250.590.591.48B1.48B
2023-07-260.660.651.53B1.50B
2023-04-260.620.611.46B1.39B
2023-01-310.640.611.35B1.33B
2022-10-270.610.621.32B1.33B
2022-07-280.630.641.37B1.40B
2022-04-260.600.571.34B1.31B
2022-01-260.510.551.33B1.35B
2021-10-270.540.531.31B1.33B
2021-07-290.640.561.38B1.38B
2021-04-200.540.471.22B1.16B
2021-01-270.500.531.19B1.26B
2020-10-210.510.441.14B984.31M
2020-07-230.340.15925.00M462.50M
2020-04-230.500.441.13B1.02B
2020-01-300.490.501.17B1.20B
2019-10-230.470.411.09B954.34M
2019-07-230.460.441.09B1.04B
2019-04-230.440.41993.00M925.30M
2019-01-310.390.39977.70M977.70M
2018-10-230.360.34906.60M856.23M
2018-07-260.410.38943.70M874.65M
2018-04-240.410.37894.80M814.12M
2018-02-010.310.30888.50M860.14M
2017-10-240.280.29821.50M841.06M
2017-07-260.320.29841.80M685.91M
2017-04-250.310.27883.50M770.71M
2017-02-010.250.24767.70M736.99M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-08Lippis Daniel J.Buy619$72.6844.99K
2026-10-08Lippis Daniel J.Sell619$85.6553.02K
2026-10-08Lippis Daniel J.Sell619$72.6844.99K
2026-09-14Markowitz WayneSell568$84.3747.92K
2026-09-13Dahl Andrew M.Sell253$84.3721.35K
2026-09-11Markowitz WayneSell355$86.7730.80K
2026-09-11Chopra DaveenSell398$86.7734.53K
2026-09-11Lippis Daniel J.Buy619$72.6844.99K
2026-09-11Lippis Daniel J.Sell619$87.5154.17K
2026-09-11Lippis Daniel J.Sell619$72.6844.99K
2026-08-31Dahl Andrew M.Sell544$91.0649.53K
2026-08-28Bruls AnnetteSell2.64K$89.98237.91K
2026-08-26Chopra DaveenBuy31.80K$72.682.31M
2026-08-26Chopra DaveenSell1.15K$91.76105.89K
2026-08-26Chopra DaveenSell30.65K$90.992.79M
2026-08-26Chopra DaveenSell31.80K$72.682.31M
2026-08-26Markowitz WayneSell1.24K$91.47113.42K
2026-08-11Lippis Daniel J.Buy619$72.6844.99K
2026-08-11Lippis Daniel J.Sell619$92.0356.97K
2026-08-11Lippis Daniel J.Sell619$72.6844.99K
2026-07-30Markowitz WayneSell146$86.0312.59K
2026-07-28Markowitz WayneBuy9.63K$74.02712.66K
2026-07-28Markowitz WayneSell9.63K$85.06818.96K
2026-07-28Markowitz WayneSell9.63K$74.02712.66K
2026-07-27Zovighian Bernard JSell320——
2026-07-27Zovighian Bernard JBuy320——
2026-07-27Zovighian Bernard JSell2.92K$83.93245.13K
2026-07-11Bruls AnnetteSell109$92.2110.05K
2026-07-10Lippis Daniel J.Buy619$72.6844.99K
2026-07-10Lippis Daniel J.Sell619$91.7056.76K
2026-07-10Lippis Daniel J.Sell619$72.6844.99K
2026-07-09Mistras TheodoraBuy12.32K——
2026-07-09Mistras TheodoraBuy87.59K——
2026-07-09Mistras TheodoraBuy61.80K$91.335.64M
2026-07-09Mistras TheodoraBuy12.32K——
2026-07-07Lippis Daniel J.Sell377$95.1835.88K
2026-06-30Lippis Daniel J.Buy619$72.6844.99K
2026-06-30Lippis Daniel J.Sell619$91.4056.58K
2026-06-30Lippis Daniel J.Sell619$72.6844.99K
2026-06-17Zovighian Bernard JSell523$87.9245.98K
2026-05-29Mistras TheodoraOther0——
2026-05-29Dahl Andrew M.Sell568$86.0848.85K
2026-05-27BOBO DONALD E JRSell23.14K$86.422.00M
2026-05-22Chopra DaveenSell1.50K$84.60126.91K
2026-05-18Lippis Daniel J.Buy620$72.6845.06K
2026-05-18Lippis Daniel J.Sell620$81.1450.31K
2026-05-18Lippis Daniel J.Sell620$72.6845.06K
2026-05-15BOBO DONALD E JRSell8.00K$81.82654.57K
2026-05-15BOBO DONALD E JRSell9.97K$82.07818.11K
2026-05-12Zovighian Bernard JSell26.64K——
2026-05-12Zovighian Bernard JBuy26.64K——
2026-05-12Zovighian Bernard JSell845$78.4066.25K
2026-05-12Zovighian Bernard JSell35.51K$77.922.77M
2026-05-11Zovighian Bernard JBuy47.21K——
2026-05-11Zovighian Bernard JSell26.20K$79.962.09M
2026-05-11Zovighian Bernard JSell47.21K——
2026-05-11BOBO DONALD E JRBuy13.46K——
2026-05-11BOBO DONALD E JRSell7.47K$79.96597.22K
2026-05-11BOBO DONALD E JRSell13.46K——
2026-05-11Chopra DaveenBuy13.58K——
2026-05-11Chopra DaveenSell7.54K$79.96602.74K
2026-05-11Chopra DaveenSell13.58K——
2026-05-11Ullem Scott B.Buy19.83K——
2026-05-11Ullem Scott B.Sell11.00K$79.96879.88K
2026-05-11Ullem Scott B.Sell19.83K——
2026-05-11Markowitz WayneSell593$79.7347.28K
2026-05-11Zovighian Bernard JSell5.49K——
2026-05-11Zovighian Bernard JBuy5.49K——
2026-05-11Lippis Daniel J.Sell362$79.9628.95K
2026-05-08Markowitz WayneSell226$82.7618.70K
2026-05-08Zovighian Bernard JSell4.22K——
2026-05-08Zovighian Bernard JSell5.40K$82.76446.74K
2026-05-08Zovighian Bernard JBuy4.22K——
2026-05-08VALERIANI NICHOLAS JBuy5.13K——
2026-05-08Sequeira RamonaBuy3.25K——
2026-05-08LORANGER STEVEN RBuy1.06K——
2026-05-08LORANGER STEVEN RBuy3.25K——
2026-05-08LAVIOLETTE PAUL ABuy3.25K——
2026-05-08STONE HEISZ LESLIEBuy3.25K——
2026-05-08GALLAHUE KIERANBuy1.06K——
2026-05-08GALLAHUE KIERANBuy3.25K——
2026-05-08Feinberg David TBuy3.25K——
2026-05-08BOBO DONALD E JRSell1.04K$82.7685.90K
2026-05-08Ullem Scott B.Sell1.66K$82.76137.46K
2026-05-08Davis Leslie C.Buy3.25K——
2026-05-08Lippis Daniel J.Sell450$82.7637.24K
2026-05-08Dahl Andrew M.Sell289$82.7623.92K
2026-05-08Chopra DaveenSell1.14K$82.7694.43K
2026-05-08Bruls AnnetteSell84$82.766.95K
2026-05-07Markowitz WayneBuy26.40K$82.762.18M
2026-05-07Markowitz WayneBuy5.20K——
2026-05-07Markowitz WayneSell264$83.2021.96K
2026-05-07Markowitz WayneBuy5.20K——
2026-05-07Zovighian Bernard JBuy245.30K$82.7620.30M
2026-05-07Zovighian Bernard JBuy43.80K——
2026-05-07Zovighian Bernard JSell4.15K$83.20345.53K
2026-05-07Zovighian Bernard JBuy43.80K——
2026-05-07BOBO DONALD E JRBuy44.00K$82.763.64M
2026-05-07BOBO DONALD E JRBuy7.85K——
2026-05-07BOBO DONALD E JRSell831$83.2069.14K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 1.38K, holders +32 vs prior quarter. Ownership 90.75%.

HolderSharesChangeChange %Value
BLACKROCK, INC.58.79M6.20M+11.79%5.32B
VANGUARD CAPITAL MANAGEMENT LLC37.62M-111.84K-0.30%3.40B
VANGUARD PORTFOLIO MANAGEMENT LLC26.41M4.38K+0.02%2.39B
STATE STREET CORP26.32M25.54K+0.10%2.38B
JPMORGAN CHASE & CO22.78M1.04M+4.78%2.08B
WELLINGTON MANAGEMENT GROUP LLP16.83M-5.18M-23.55%1.52B
GEODE CAPITAL MANAGEMENT, LLC15.44M2.30M+17.54%1.39B
BANK OF NEW YORK MELLON CORP14.08M-2.65M-15.85%1.27B
DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN13.00M191.06K+1.49%1.18B
NINETY ONE UK LTD12.34M-58.64K-0.47%1.12B
ARISTOTLE CAPITAL MANAGEMENT, LLC8.67M8.67MNew783.91M
FMR LLC8.44M-6.07M-41.84%763.12M
NORGES BANK8.37M8.37MNew757.49M
ALLIANCEBERNSTEIN L.P.8.66M5.19M+149.77%693.53M
BROWN ADVISORY INC7.37M336.48K+4.79%666.33M
BANK OF AMERICA CORP /DE/6.69M2.81M+72.33%605.40M
ARTISAN PARTNERS LIMITED PARTNERSHIP6.63M1.42M+27.39%599.36M
MORGAN STANLEY6.34M-721.51K-10.22%573.46M
DEUTSCHE BANK AG\5.71M-344.74K-5.69%516.55M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP5.68M3.79M+200.25%513.57M
NORTHERN TRUST CORP5.67M-153.14K-2.63%513.02M
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC5.49M30.50K+0.56%496.50M
WELLCOME TRUST LTD (THE) AS TRUSTEE OF THE WELLCOME TRUST4.80M00.00%434.21M
GOLDMAN SACHS GROUP INC4.55M-532.94K-10.49%411.51M
LEGAL & GENERAL GROUP PLC4.30M-148.33K-3.33%389.09M

Insights

Revenue by product
PeriodValue
FY2010Critical Care: 454100000.0, Surgical Heart Valve Therapy: 838300000.0
FY2011Critical Care: 508300000.0, Surgical Heart Valve Therapy: 1010700000.0
FY2012Critical Care: 560000000.0, Surgical Heart Valve Therapy: 787500000.0, Transcatheter Heart Valves: 552100000.0
FY2013Critical Care: 536600000.0, Surgical Heart Valve Therapy: 801200000.0, Transcatheter Heart Valves: 707700000.0
FY2014Critical Care: 553200000.0, Surgical Heart Valve Therapy: 826100000.0, Transcatheter Heart Valves: 943600000.0
FY2015Critical Care: 528400000.0, Surgical Heart Valve Therapy: 785000000.0, Transcatheter Heart Valves: 1180300000.0
FY2016Critical Care: 560300000.0, Surgical Heart Valve Therapy: 774900000.0, Transcatheter Heart Valves: 1628500000.0
FY2017Critical Care: 601000000.0, Surgical Heart Valve Therapy: 807100000.0, Transcatheter Heart Valves: 2027200000.0
FY2018Critical Care: 674500000.0, Surgical Heart Valve Therapy: 761600000.0, Transcatheter Heart Valves: 2286700000.0
FY2019Critical Care: 740200000.0, Surgical Heart Valve Therapy: 841700000.0, Transcatheter Heart Valves: 2737900000.0, Transcatheter Mitral And Tricuspid Therapies: 28200000.0
FY2020Critical Care: 725400000.0, Surgical Heart Valve Therapy: 761800000.0, Transcatheter Heart Valves: 2857300000.0, Transcatheter Mitral And Tricuspid Therapies: 41800000.0
FY2021Critical Care: 834900000.0, Surgical Heart Valve Therapy: 889100000.0, Transcatheter Heart Valves: 3422500000.0, Transcatheter Mitral And Tricuspid Therapies: 86000000.0
FY2022Critical Care: 855000000.0, Surgical Heart Valve Therapy: 893100000.0, Transcatheter Heart Valves: 3518200000.0, Transcatheter Mitral And Tricuspid Therapies: 116100000.0
FY2023Critical Care: 928100000.0, Surgical Heart Valve Therapy: 999300000.0, Transcatheter Heart Valves: 3879800000.0, Transcatheter Mitral And Tricuspid Therapies: 197600000.0
FY2024Surgical Heart Valve Therapy: 981300000.0, Transcatheter Heart Valves: 4106100000.0, Transcatheter Mitral And Tricuspid Therapies: 352100000.0
FY2025Surgical Heart Valve Therapy: 1029300000.0, Transcatheter Heart Valves: 4487700000.0, Transcatheter Mitral And Tricuspid Therapies: 550600000.0
Revenue by region
PeriodValue
FY2010Rest of World: 879400000.0, UNITED STATES: 567600000.0
FY2011Europe: 574000000.0, JAPAN: 283700000.0, Rest of World: 215300000.0, UNITED STATES: 605600000.0
FY2012Europe: 559700000.0, JAPAN: 294100000.0, Rest of World: 233700000.0, UNITED STATES: 812100000.0
FY2013Europe: 616500000.0, JAPAN: 243600000.0, Rest of World: 245800000.0, UNITED STATES: 939600000.0
FY2014Europe: 741400000.0, JAPAN: 270800000.0, UNITED STATES: 1047300000.0
FY2015Europe: 717300000.0, JAPAN: 246200000.0, Rest of World: 267300000.0, UNITED STATES: 1262900000.0
FY2016Europe: 749000000.0, JAPAN: 309300000.0, Rest of World: 289700000.0, UNITED STATES: 1615700000.0
FY2017Europe: 831000000.0, JAPAN: 350300000.0, Rest of World: 346400000.0, UNITED STATES: 1907600000.0
FY2018Europe: 885100000.0, JAPAN: 396800000.0, Rest of World: 385600000.0, UNITED STATES: 2055300000.0
FY2019Europe: 941200000.0, JAPAN: 444700000.0, Rest of World: 429400000.0, UNITED STATES: 2532700000.0
FY2020Europe: 973600000.0, JAPAN: 460100000.0, Rest of World: 435800000.0, UNITED STATES: 2516800000.0
FY2021Europe: 1190300000.0, JAPAN: 528900000.0, Rest of World: 550200000.0, UNITED STATES: 2963100000.0
FY2022Europe: 1174800000.0, JAPAN: 473600000.0, Rest of World: 601400000.0, UNITED STATES: 3132600000.0
FY2023Europe: 1334500000.0, JAPAN: 452400000.0, Rest of World: 709200000.0, UNITED STATES: 3508700000.0
FY2024Europe: 1321700000.0, JAPAN: 339800000.0, Rest of World: 572000000.0, UNITED STATES: 3206000000.0
FY2025Europe: 1517500000.0, JAPAN: 354700000.0, Rest of World: 652300000.0, UNITED STATES: 3543100000.0

Insights · Dividends · Forecast · Learn

Stocklytics home · Screener